[1]
|
Chen, Z.Y., Gordillo-Martinez, F., Jiang, L., et al. (2021) Zinc Ameliorates Human Aortic Valve Calcification through GPR39 Mediated ERK1/2 Signalling Pathway. Cardiovascular Researches, 117, 820-835.
https://doi.org/10.1093/cvr/cvaa090
|
[2]
|
Rodriguez-Gabella, T., Voisine, P., Puri, R., Pibarot, P. and Rodes-Cabau, J. (2017) Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration. Journal of the American College of Cardiology, 70, 1013-1028. https://doi.org/10.1016/j.jacc.2017.07.715
|
[3]
|
Kossar, A.P., Wanda, A., Grau, J.B., et al. (2020) Circulating and Tissue Matricellular RNA and Protein Expression in Calcific Aortic Valve Disease. Physiological Genomics, 52, 191-199.
https://doi.org/10.1152/physiolgenomics.00104.2019
|
[4]
|
Natarajan, B., Aaron, W. and Pushpa, P. (2015) Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice. Journal of Visualized Experiments, No. 96, Arttcle 52538.
|
[5]
|
Villa-Bellosta, R. (2021) Vascular Calcification: Key Roles of Phosphate and Pyrophosphate. Inter-national Journal of Molecular Sciences, 22, Article 13536. https://doi.org/10.3390/ijms222413536
|
[6]
|
Lu, W.T., Hynek, P., Abdonas, T., et al. (2022) Prevalence, Awareness, Treatment and Control of Hypertension, Diabetes and Hy-percholesterolemia, and Associated Risk Factors in the Czech Republic, Russia, Poland and Lithuania: a Cross-Sectional Study. BMC Public Health, 22, Article No. 883. https://doi.org/10.1186/s12889-022-13260-3
|
[7]
|
Liu, Z.H., Li, J.Y., Liu, H.Y., et al. (2019) The Intestinal Microbiota Associated with Cardiac Valve Calcification Differs from that of Coronary Artery Disease. Atherosclerosis, 284, 121-128.
https://doi.org/10.1016/j.atherosclerosis.2018.11.038
|
[8]
|
Song, R., Fullerton, D.A., Ao, L., et al. (2017) Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves. Journal of the American Heart Association, 6, e005364.
https://doi.org/10.1161/JAHA.116.005364
|
[9]
|
Juul, H.J. (2007) The Physiology of Glucagon-Like Peptide 1. Physiological Reviews, 87, 1409-1439.
https://doi.org/10.1152/physrev.00034.2006
|
[10]
|
Charles, P., Scott, H.R., Kirk, R.K., et al. (2014) GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed with Extensively Validated Monoclonal Anti-body. Endocrinology, 155, 1280-1290.
https://doi.org/10.1210/en.2013-1934
|
[11]
|
Chen, Y., Xu, Y.N., Ye, C.Y., et al. (2022) GLP-1 Mimetics as a Po-tential Therapy for Nonalcoholic Steatohepatitis. Acta Pharmacologica Sinica, 43, 1156-1166. https://doi.org/10.1038/s41401-021-00836-9
|
[12]
|
Saraiva, J.F.K. and Franco, D. (2021) Oral GLP-1 Analogue: Perspectives and Impact on Atherosclerosis in Type 2 Diabetic Patients. Cardiovascular Diabetology, 20, Article No. 235. https://doi.org/10.1186/s12933-021-01417-0
|
[13]
|
Baggio, L.L., Yusta, B., Mulvihill, E.E., et al. (2018) GLP-1 Receptor Expression within the Human Heart. Endocrinology, 159, 1570-1584. https://doi.org/10.1210/en.2018-00004
|
[14]
|
Drucker, D.J. (2002) Biological Actions and Therapeutic Potential of the Glucagon-Like Peptides. Gastroenterology, 122, 531-544. https://doi.org/10.1053/gast.2002.31068
|
[15]
|
Duan, L.H., Rao, X.Q., Braunstein, Z., et al. (2017) Role of Incretin Axis in Inflammatory Bowel Disease. Frontiers in Immu-nology, 8, Article 1734. https://doi.org/10.3389/fimmu.2017.01734
|
[16]
|
Drucker, D.J. (2018) Mechanisms of Ac-tion and Therapeutic Application of Glucagon-Like Peptide-1. Cell Metabolism, 27, 740-756. https://doi.org/10.1016/j.cmet.2018.03.001
|
[17]
|
Müller, T.D., Finan, B., Bloom, S.R., et al. (2019) Glucagon-Like Peptide 1 (GLP-1). Molecular Metabolism, 30, 72-130. https://doi.org/10.1016/j.molmet.2019.09.010
|
[18]
|
Sandoval, D. (2008) CNS GLP-1 Regulation of Peripheral Glucose Homeostasis. Physiology & Behavior, 94, 670-674.
https://doi.org/10.1016/j.physbeh.2008.04.018
|
[19]
|
Burmeister, M.A., Brown, J.D., Ayala, J.E., et al. (2017) The Glucagon-Like Peptide-1 Receptor in the Ventromedial Hypothalamus Reduces Short-Term Food Intake in Male Mice by Regulating Nutrient Sensor Activity. The American Journal of Physiology-Endocrinology and Metabolism, 313, E651-E662.
https://doi.org/10.1152/ajpendo.00113.2017
|
[20]
|
Alessia, C., Minrong, A., Nicolas, N., et al. (2022) Anorectic and Aversive Effects of GLP-1 Receptor Agonism Are Mediated by Brainstem Cholecystokinin Neurons, and Modulated by GIP Receptor Activation. Molecular Metabolism, 55, Article 101407. https://doi.org/10.1016/j.molmet.2021.101407
|
[21]
|
Gribble, F.M. and Reimann, F. (2019) Function and Mecha-nisms of Enteroendocrine Cells and Gut Hormones in Metabolism. Nature Reviews Endocrinology, 15, 226-237. https://doi.org/10.1038/s41574-019-0168-8
|
[22]
|
Qu, L., Matz, A.J., Karlinsey, K., Cao, Z., Vella, A.T. and Zhou, B. (2022) Macrophages at the Crossroad of Meta-Inflammation and Inflammaging. Genes, 13, Article 2074. https://doi.org/10.3390/genes13112074
|
[23]
|
Moro-García, M.A., Mayo, J.C., Sainz, R.M. and Alonso-Arias, R. (2018) Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes. Frontiers in Immunology, 9, Article 339. https://doi.org/10.3389/fimmu.2018.00339
|
[24]
|
Daisuke, S., Yukio, F., Yoshihiro, K., et al. (2012) Glucagon-Like Peptide-1 (GLP-1) Induces M2 Polarization of Human Macro-phages via STAT3 Activation. Biochemical and Biophysical Research Communications, 425, 304-308.
https://doi.org/10.1016/j.bbrc.2012.07.086
|
[25]
|
Lumeng, C.N., Bodzin, J.L. and Saltiel, A.R. (2007) Obesity In-duces a Phenotypic Switch in Adipose Tissue Macrophage Polarization. The Journal of Clinical Investigation, 117, 175-184. https://doi.org/10.1172/JCI29881
|
[26]
|
Shiho, F., Isao, U., Agussalim, B., et al. (2009) Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice. Diabetes, 58, 2574-2582. https://doi.org/10.2337/db08-1475
|
[27]
|
Ángela, V., Jorge, N., Herrero-Cervera, A., et al. (2017) The GLP-1 Ana-logue Lixisenatide Decreases Atherosclerosis in Insulin-Resistant Mice by Modulating Macrophage Phenotype. Dia-betologia, 60, 1801-1812.
https://doi.org/10.1007/s00125-017-4330-3
|
[28]
|
Zubair, S., Thomas, K., Deiuliis, J.A., et al. (2011) Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis. Circulation, 124, 2338-2349.
https://doi.org/10.1161/CIRCULATIONAHA.111.041418
|
[29]
|
Noritaka, S., Kei, A., Nakamura, N., et al. (2020) Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis. Journal of Diabe-tes Research, 2020, Article ID: 8843310.
https://doi.org/10.1155/2020/8843310
|
[30]
|
Mitchell, P.D., Salter, B.M., Oliveria, J.P., et al. (2017) Glucagon-Like Peptide-1 Receptor Expression on Human Eosinophils and Its Regulation of Eosinophil Activation. Clinical & Experi-mental Allergy, 47, 331-338.
https://doi.org/10.1111/cea.12860
|
[31]
|
Su, Y.F., Liu, N., Zhang, Z.J., et al. (2022) Cholecystokinin and Gluca-gon-Like Peptide-1 Analogues Regulate Intestinal Tight Junction, Inflammation, Dopaminergic Neurons and α-Synuclein Accumulation in the Colon of Two Parkinson’s Disease Mouse Models. European Journal of Pharmacology, 926, Arti-cle 175029.
https://doi.org/10.1016/j.ejphar.2022.175029
|
[32]
|
Toki, S., Newcomb, D.C., Printz, R.L., Cahill, K.N., Boyd, K.L., Niswender, K.D. and Peebles Jr., R.S. (2021) Glucagon-Like Peptide-1 Receptor Agonist Inhibits Aeroallergen-Induced Activation of ILC2 and Neutrophilic Airway Inflammation in Obese Mice. Allergy, 76, 3433-3445. https://doi.org/10.1111/all.14879
|
[33]
|
Shan, Y., Tan, S., Lin, Y., Liao, S., Zhang, B., Chen, X., Wang, J., Deng, Z., Zeng, Q., Zhang, L., Wang, Y., Hu, X., Qiu, W., Peng, L. and Lu, Z. (2019) The Glucagon-Like Peptide-1 Receptor Agonist Reduces Inflammation and Blood-Brain Barrier Breakdown in an Astrocyte-Dependent Manner in Experimental Stroke. Journal of Neuroinflammation, 16, Article No. 242. https://doi.org/10.1186/s12974-019-1638-6
|
[34]
|
Kamiya, M., Mizoguchi, F. and Yasuda, S. (2022) Amelioration of Inflammatory Myopathies by Glucagon-Like Peptide-1 Receptor Agonist via Suppressing Muscle Fibre Necroptosis. Journal of Cachexia, Sarcopenia and Muscle, 13, 2118-2131. https://doi.org/10.1002/jcsm.13025
|
[35]
|
Sun, M., Wu, X., Yu, Y., Wang, L., Xie, D., Zhang, Z., Chen, L., Lu, A., Zhang, G. and Li, F. (2020) Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. Frontiers in Cell and Developmental Biolo-gy, 8, Article 576110. https://doi.org/10.3389/fcell.2020.576110
|
[36]
|
Chen, K., Wu, R., Mo, B., Yan, X., Shen, D. and Chen, M. (2021) Comparison between Liraglutide Alone and Liraglutide in Combination with Insulin on Osteopo-rotic Rats and Their Effect on Bone Mineral Density. Journal of Musculoskeletal and Neuronal Interactions, 21, 142-148.
|
[37]
|
Trautvetter, U. and Jahreis, G. (2014) Effect of Supplementary Calcium Phosphate on Plasma Gastroin-testinal Hormones in a Double-Blind, Placebo-Controlled, Cross-Over Human Study. British Journal of Nutrition, 111, 287-293.
https://doi.org/10.1017/S0007114513002341
|
[38]
|
Zhang, S., Lachance, B.B., Mattson, M.P. and Jia, X. (2021) Glucose Metabolic Crosstalk and Regulation in Brain Function and Diseases. Progress in Neurobiology, 204, Article 102089.
https://doi.org/10.1016/j.pneurobio.2021.102089
|
[39]
|
Segatto, M., Cutone, A. and Pallottini, V. (2022) Fat Check-ing: Emerging Role of Lipids in Metabolism and Disease. International Journal of Molecular Sciences, 23, Article 13842. https://doi.org/10.3390/ijms232213842
|
[40]
|
Muscella, A., Stefàno, E., Lunetti, P., Capobianco, L. and Marsigliante, S. (2020) The Regulation of Fat Metabolism During Aerobic Exercise. Biomolecules, 10, Article 1699. https://doi.org/10.3390/biom10121699
|
[41]
|
Quarta, C., Stemmer, K., Novikoff, A., Yang, B., Klingelhuber, F., Harger, A., Bakhti, M., Bastidas-Ponce, A., Baugé, E., Campbell, J.E., Capozzi, M., Clemmensen, C., Collden, G., Cota, P., Douros, J., Drucker, D.J., DuBois, B., Feuchtinger, A., Garcia-Caceres, C., Grandl, G., Hennuyer, N., Herzig, S., Hofmann, S.M., Knerr, P.J., Kulaj, K., Lalloyer, F., Lickert, H., Liskiewicz, A., Liskiewicz, D., Maity, G., Perez-Tilve, D., Prakash, S., Sanchez-Garrido, M.A., Zhang, Q., Staels, B., Krahmer, N., DiMarchi, R.D., Tschöp, M.H., Finan, B. and Müller, T.D. (2022) GLP-1-Mediated Delivery of Tesaglitazar Improves Obesity and Glucose Metabolism in Male Mice. Nature Metabolism, 4, 1071-1083.
https://doi.org/10.1038/s42255-022-00617-6
|
[42]
|
Lyseng-Williamson, K.A. (2019) Glucagon-Like Peptide-1 Re-ceptor Analogues in Type 2 Diabetes: Their Use and Differential Features. Clinical Drug Investigation, 39, 805-819. https://doi.org/10.1007/s40261-019-00826-0
|
[43]
|
Timper, K., Del Río-Martín, A., Cremer, A.L., Bremser, S., Al-ber, J., Giavalisco, P., Varela, L., Heilinger, C., Nolte, H., Trifunovic, A., Horvath, T.L., Kloppenburg, P., Backes, H. and Brüning, J.C. (2020) GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integ-rity, and Function. Cell Metabolism, 31, 1189-1205.
https://doi.org/10.1016/j.cmet.2020.05.001
|
[44]
|
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. and Relman, D.A. (2005) Diversity of the Human Intestinal Microbial Flora. Science, 308, 1635-1638.
https://doi.org/10.1126/science.1110591
|
[45]
|
Jin, M., Qian, Z., Yin, J., Xu, W. and Zhou, X. (2019) The Role of Intestinal Microbiota in Cardiovascular Disease. Journal of Cellular and Molecular Medicine, 23, 2343-2350. https://doi.org/10.1111/jcmm.14195
|
[46]
|
Ma, Y., You, X., Mai, G., Tokuyasu, T. and Liu, C. (2018) A Human Gut Phage Catalog Correlates the Gut Phageome with Type 2 Diabetes. Microbiome, 6, Article No. 24. https://doi.org/10.1186/s40168-018-0410-y
|
[47]
|
Zhang, J.M., Sun, Y.S., Zhao, L.Q., Chen, T.T., Fan, M.N., Jiao, H.C., Zhao, J.P., Wang, X.J., Li, F.C., Li, H.F. and Lin, H. (2019) SCFAs-Induced GLP-1 Secretion Links the Regula-tion of Gut Microbiome on Hepatic Lipogenesis in Chickens. Frontiers in Microbiology, 10, Article 2176. https://doi.org/10.3389/fmicb.2019.02176
|
[48]
|
Kato, S., Sato, T., Fujita, H., Kawatani, M. and Yamada, Y. (2021) Effects of GLP-1 Receptor Agonist on Changes in the Gut Bacterium and the Underlying Mechanisms. Scientific Reports, 11, Article No. 9167.
https://doi.org/10.1038/s41598-021-88612-x
|
[49]
|
Chen, L., Heikkinen, L., Wang, C., Yang, Y., Sun, H. and Wong, G. (2019) Trends in the Development of miRNA Bioinformatics Tools. Briefings in Bioinformatics, 20, 1836-1852.
|
[50]
|
王卫杰, 刘新颖, 赵文爱, 李泽民. 视蛋白[J]. 生命的化学, 2009, 29(3): 440-443.
|
[51]
|
Feuda, R., Menon, A.K. and Göpfert, M.C. (2022) Rethinking Opsins. Molecular Biology and Evolution, 39, msac033.
https://doi.org/10.1093/molbev/msac033
|
[52]
|
田壮, 汪雕雕, 张矗, 李汉臣, 周建, 姚琦. 骨形态发生蛋白2间接调控骨细胞骨硬化蛋白基因表达的机制[J]. 中国组织工程研究, 2022, 26(11): 1686-1691.
|
[53]
|
Mohler III, E.R., et al. (2001) Bone Formation and Inflammation in Cardiac Valves. Circulation, 103, 1522-1528.
https://doi.org/10.1161/01.CIR.103.11.1522
|
[54]
|
Demer, L.L., et al. (1994) Mechanism of Calcification in Athero-sclerosis. Trends in Cardiovascular Medicine, 4, 45-49.
https://doi.org/10.1016/1050-1738(94)90025-6
|
[55]
|
David, L., et al. (2009) Emerging role of Bone Morphogenetic Proteins in Angiogenesis. Cytokine & Growth Factor Reviews, 20, 203-212. https://doi.org/10.1016/j.cytogfr.2009.05.001
|
[56]
|
Capuani, B., Pacifici, F., Della-Morte, D. and Lauro, D. (2018) Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs. Frontiers in Endocrinology, 9, Article 719.
https://doi.org/10.3389/fendo.2018.00719
|
[57]
|
MacDonald, P.E., El-Kholy, W., Riedel, M.J., Salapatek, A.M., Light, P.E. and Wheeler, M.B. (2002) The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Se-cretion. Diabetes, 3, S434-S442.
https://doi.org/10.2337/diabetes.51.2007.S434
|
[58]
|
Shang, J., Li, J., Keller, M.P., Hohmeier, H.E., Wang, Y., Feng, Y., Zhou, H.H., Shen, X., Rabaglia, M., Soni, M., Attie, A.D., Newgard, C.B., Thornberry, N.A., Howard, A.D. and Zhou, Y.P. (2015) Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells. Molecular Endocrinology, 29, 1243-1253. https://doi.org/10.1210/me.2014-1335
|
[59]
|
Wei, J., Ding, D., Wang, T., Liu, Q. and Lin, Y. (2017) MiR-338 Con-trols BPA-Triggered Pancreatic Islet Insulin Secretory Dysfunction from Compensation to Decompensation by Targeting Pdx-1. The FASEB Journal, 31, 5184-5195.
https://doi.org/10.1096/fj.201700282R
|
[60]
|
Hebsgaard, J.B., Pyke, C., Yildirim, E., Knudsen, L.B., Heegaard, S. and Kvist, P.H. (2018) Glucagon-Like Peptide-1 Receptor Expression in the Human Eye. Diabetes, Obesity and Metabo-lism, 20, 2304-2308.
https://doi.org/10.1111/dom.13339
|
[61]
|
聂元鹏, 何学敏, 陈燕铭. 胰高血糖素样肽1受体激动剂在糖尿病视网膜病变中的应用进展[J]. 中国实用内科杂志, 2020, 40(11): 947-951.
|
[62]
|
Takada, I., Kouzmenko, A.P. and Kato, S. (2010) PPAR-Gamma Signaling Crosstalk in Mesenchymal Stem Cells. PPAR Research, 2010, Article ID: 341671.
|
[63]
|
丁海璇, 李铁力, 田园, 杨丽. 胰高血糖素样肽-1在骨质疏松症中的影响及作用机制的研究进展[J]. 中国骨质疏松杂志, 2022, 28(9): 1379-1384.
|
[64]
|
王婷, 董进. 胰高血糖素样肽-1类似物对人成骨细胞Wnt信号通路相关基因表达的影响[J]. 中国骨质疏松杂志, 2013, 19(6): 580-583.
|
[65]
|
Drucker, D.J. (2022) GLP-1 Physiology Informs the Pharmacotherapy of Obesity. Molecular Metabolism, 57, Article 101351. https://doi.org/10.1016/j.molmet.2021.101351
|
[66]
|
Liao, E.P. (2012) Management of Type 2 Diabetes: New and Future Developments in Treatment. The American Journal of Medicine. 125, S2-S3. https://doi.org/10.1016/j.amjmed.2012.05.008
|
[67]
|
Li, Y., Perry, T., Kindy, M.S., Harvey, B.K., Tweedie, D., Holloway, H.W., Powers, K., Shen, H., Egan, J.M., Sambamurti, K., Brossi, A., Lahiri, D.K., Mattson, M.P., Hoffer, B.J., Wang, Y. and Greig, N.H. (2009) GLP-1 Receptor Stimulation Preserves Primary Cortical and Dopaminergic Neu-rons in Cellular and Rodent Models of Stroke and Parkinsonism. The Proceedings of the National Academy of Sciences, 106, 1285-1290.
https://doi.org/10.1073/pnas.0806720106
|
[68]
|
Xiao, F., Zha, Q., Zhang, Q., Wu, Q., Chen, Z., Yang, Y., Yang, K. and Liu, Y. (2021) Decreased Glucagon-Like Peptide-1 Is Associated with Calcific Aortic Valve Disease: GLP-1 Sup-presses the Calcification of Aortic Valve Interstitial Cells. Frontiers in Cardiovascular Medicine, 8, Article 709741. https://doi.org/10.3389/fcvm.2021.709741
|
[69]
|
查晴, 肖凡, 张倩茹, 叶佳雯, 张煜, 杨玲, 杨克, 刘艳. 主动脉瓣膜钙化中胰高血糖素样肽-1对Notch1-Sox9信号通路的调控作用[J]. 国际心血管病杂志, 2021, 48(6): 370-375+379.
|
[70]
|
国家统计局. 第七次全国人口普查公报(第五号)——人口年龄构成情况[J]. 中国统计, 2021(5): 10-11.
|
[71]
|
Coffey, S., d’Arcy, J.L., Loudon, M.A., Mant, D., Farmer, A.J., Prendergast, B.D. and Ox-VALVEPCS Group (2014) The OxVALVE Population Cohort Study (OxVALVE-PCS)—Population Screening for Undiagnosed Valvular Heart Disease in the Elderly: Study Design and Objectives. Open Heart, 1, e000043.
https://doi.org/10.1136/openhrt-2014-000043
|
[72]
|
van Engeland, N.C.A., Bertazzo, S., Sarathchandra, P., et al. (2017) Aortic Calcified Particles Modulate Valvular Endothelial and Interstitial Cells. Cardiovascular Pathology, 28, 36-45. https://doi.org/10.1016/j.carpath.2017.02.006
|